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Information on medicines provided to doctors should be of high quality to support the quality use
of medicines. Pharmaceutical promotion is used by pharmaceutical companies to
disseminate information about their medicines to doctors. Although the companies claim that
promotion offers evidence-based information, research shows that pharmaceutical promotion
often provide bias and poor quality of information that may negatively influence doctors'
prescribing behaviour. In Malaysia, the pharmaceutical market is highly competitive. It appears
that pharmaceutical companies actively promoting their medicines to Malaysian doctors. Given
the absence of a comprehensive independent source of prescribing information in Malaysia,
Malaysian doctors may be more likely to rely on medicines information provided by
pharmaceutical companies. Clearly, pharmaceutical promotional activities in Malaysia need to be
effectively regulated. This article will discuss the regulation of pharmaceutical promotion and
current policy challenges in Malaysia.
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